Insulin glargine (GLAR) improves health related quality of life (HRQOL) in patients with type 2 diabetes (T2DM) inadequately controlled on sulfonylurea plus metformin (SU plus MET)

被引：0
|
作者：
Vinik, AI
Dailey, G
Zhang, Q
机构：
来源：
DIABETES | 2005年 / 54卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A142 / A142
页数：1
相关论文
共 50 条
  • [21] Insulin Degludec/Liraglutide (IDegLira) Improves Patient-Reported Impacts in Subjects with Type 2 Diabetes (T2D) Inadequately Controlled on Insulin Glargine (IG) plus Metformin (Met): DUAL V Study
    Brod, Meryl
    Manghi, Federico C. Perez
    Garcia-Hernandez, Pedro A.
    Norwood, Paul
    Jarlov, Henrik
    Kongso, Jens Harald
    Lingvay, Ildiko
    [J]. DIABETES, 2015, 64 : A644 - A644
  • [22] Comparison of 2 Algorithms for Adding Insulin Glargine (GLA) to Metformin (MET) in Patients (Pts) with T2DM
    Dailey, George
    Traylor, Louise
    Gill, Jasvinder
    [J]. DIABETES, 2015, 64 : A266 - A266
  • [23] Comparison of glargine insulin versus rosiglitazone addition in poorly controlled type 2 diabetic patients on metformin plus sulfonylurea
    Triplitt, Curtis
    Glass, Leonard
    Miyazaki, Yoshiniro
    Wajcberg, Estela
    Gastaldelli, Amalia
    De Filippis, Elena
    Cersosimo, Eugenio
    DeFronzo, Ralph A.
    [J]. DIABETES CARE, 2006, 29 (11) : 2371 - 2377
  • [24] Benefits of a Fixed-Ratio Formulation of Once-Daily Insulin Glargine/Lixisenatide (LixiLan) vs. Glargine in Type 2 Diabetes (T2DM) Inadequately Controlled on Metformin
    Rosenstock, Julio
    Diamant, Michaela
    Silvestre, Louise
    Souhami, Elisabeth
    Zhou, Tianyue
    Fonseca, Vivian
    [J]. DIABETES, 2014, 63 : A87 - A88
  • [25] Efficacy and tolerability of vildagliptin added to a sulfonylurea (SU) in patients with type 2 diabetes (T2DM)
    Garber, A. J.
    Camisasca, R.-P.
    Jauffret, S.
    Baron, M. A.
    [J]. DIABETES, 2007, 56 : A134 - A134
  • [26] Health-related Quality-of-Life (HRQoL) Implications of Cardiovascular Events in Type 2 Diabetes Mellitus (T2DM)
    Briggs, Andrew
    Bhatt, Deepak
    Scirica, Benjamin M.
    Mosenzon, Ofri
    Johnston, Karissa
    Szabo, Shelagh
    Bergenheim, Klas
    Mukherjee, Jayanti
    Hirshberg, Boaz
    Raz, Itamar
    [J]. DIABETES, 2015, 64 : A659 - A659
  • [27] Efficacy and safety of saxagliptin plus metformin versus acarbose plus metformin in type 2 diabetes patients inadequately controlled with metformin monotherapy
    Du, J.
    Liang, L.
    Fang, H.
    Xu, F.
    Li, W.
    Shen, L.
    Mu, Y.
    [J]. DIABETOLOGIA, 2016, 59 : S372 - S372
  • [28] Triple therapy in type 2 diabetes - Insulin glargine or rosiglitazone added to combmiation therapy of sulfonylurea plus metformin in insulin-naive patients
    Rosenstock, J
    Sugimoto, D
    Strange, P
    Stewart, JA
    Soltes-Rak, E
    Dailey, G
    [J]. DIABETES CARE, 2006, 29 (03) : 554 - 559
  • [29] Efficacy of Combination of Insulin Glargine with either Metformin or Sulfonylurea in Patients with Poorly Controlled Type 2 Diabetes
    Chuang, Shih-Ming
    Wang, Chao-Hung
    Liu, Sung-Chen
    Chien, Ming-Nan
    Chen, Wei-Che
    [J]. INTERNATIONAL JOURNAL OF GERONTOLOGY, 2020, 14 (02) : 138 - 141
  • [30] Glycemic control and safety of insulin glargine (GLAR) in elderly patients with type 2 diabetes mellitus (T2DM): The GOAL A1C study
    Halter, Jeffrey B.
    Kennedy, Laurence
    Herman, William H.
    Miller, Michael E.
    [J]. DIABETES, 2006, 55 : A114 - A115
12345